09/18/2013 - 06:09

 An international team of researchers, led by scientists at The Genome Institute at Washington University School of Medicine in St. Louis and the University of Michigan School of Public Health in Ann Arbor, has identified a gene mutation linked to age-related macular degeneration (AMD), the leading cause of blindness in Americans over age 50.


02/15/2013 - 10:27

Researchers don’t know the exact cause of Behçet's disease, a chronic condition that leads to oral and genital sores and serious complications such as blindness, but new research brings better understanding to what makes some people more susceptible to being affected. Study identifies regions of genes linked to Behçet’s, a poorly understood condition that causes painful and serious symptoms, including ulcers and brain inflammation.


01/22/2013 - 14:52

Independent clinical trials, including one conducted at the Scheie Eye Institute at the Perelman School of Medicine, have reported safety and efficacy for Leber congenital amaurosis (LCA), a congenital form of blindness caused by mutations in a gene (RPE65) required for recycling vitamin A in the retina. Inherited retinal degenerative diseases were previously considered untreatable and incurable.

12/19/2012 - 16:01

People who regularly took aspirin 10 years prior to examination had a small but statistically significant increase in the risk of a subtype of age-related macular degeneration (AMD), according to a study by University of Wisconsin-Madison researchers.

04/27/2012 - 11:26

Results from the largest genetic study of glaucoma, a leading cause of blindness and vision loss worldwide, showed that two genetic variations are associated with primary open angle glaucoma (POAG), a common form of the disease. The identification of genes responsible for this disease is the first step toward the development of gene-based disease detection and treatment.

04/03/2012 - 22:54

Working in mice, scientists at Washington University School of Medicine in St. Louis have devised a treatment that prevents the optic nerve injury that occurs in glaucoma, a neurodegenerative disease that is a leading cause of blindness.